Comparing different triple-drug combinations.
Replacing the PI with abacavir in a triple-drug regimen resulted in continued plasma viral-load suppression and improvements in lipid abnormalities. In another study, PI-containing triple-drug combinations were more likely to reduce viral burden in lymphoid tissue than were PI-sparing regimens.
Albrecht
H
H
Division of Infectious Diseases, Emory University School of Medicine, Atlanta, USA.
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D019562:Viral Load
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors